Objective: The role of intrauterine hyperglycemia and future risk of type 2 diabetes in human offspring is debated. We studied glucose tolerance in adult offspring of women with either gestational diabetes (GDM) or type 1 diabetes, taking the impact of both intrauterine hyperglycemia and genetic predisposition to type 2 diabetes into account.
he rapid global rise in the prevalence of type 2 diabetes constitutes a health threat to the individual and is a major burden for health economy. Therefore it is crucial to identify specific risk-groups targeting preventive strategies. Studies of developmental origins of health and disease have put focus on the possible role of intrauterine hyperglycemia in the pathogenesis of type 2 diabetes (1). Maternal glucose crosses placenta easily, and maternal hyperglycemia leads to intrauterine hyperglycemia, fetal hyperinsulinemia and possible modification of growth and development of the fetus (2) .
Pronounced hyperglycemia in relation to pregnancies of women with type 1 diabetes as well as mild hyperglycemia, as seen among women with gestational diabetes mellitus (GDM), are both associated with increased fetal growth and perinatal morbidity (3, 4) . Also less severe forms of glucose intolerance are associated with increased feto-maternal morbidity (5) .
In animal studies, intrauterine hyperglycemia increases the risk of abnormal glucose tolerance, diabetes, overweight and insulin-resistance in the offspring (6) (7) (8) (9) (10) . Despite the very convincing animal studies, questions still exist concerning the long-term impact of intrauterine hyperglycemia in humans, especially regarding the impact in adult Caucasian. Observational studies as well as prospective studies among the Pima Indians and from the Chicago group support the findings of animal studies (11) (12) (13) (14) (15) (16) (17) (18) . The studies of the Pima Indians examine children and adult offspring; in contrast to the majority of the other studies where offspring before the end of puberty are investigated (14) (15) (16) 18) . Due to the very specific genetics of the Pima Indians the results are not directly applicable to other populations (11) (12) (13) 19) . Furthermore some of the other studies have limitations due to: A small number of participants (17) , a high number of drop outs during follow-up (14, 15) and analyses including maternal type 1 and type 2 diabetes together (16) . Only one follow-up study of children from a small randomized trial in women with GDM has been performed; without definitive conclusions (20) .
Thus in the present paper we aimed to evaluate the prevalence of type 2 diabetes and pre-diabetes in young adult offspring of women with either diet treated GDM or type 1 diabetes in a mainly Nordic Caucasian population; taking the impact of both intrauterine hyperglycemia and genetic predisposition to type 2 diabetes into account.
RESEARCH DESIGN AND METHODS

Subjects. Through 2002-2005
we did a follow-up study of 597 adult offspring born to women with GDM or type 1 diabetes and from two control groups. All subjects were born at Department of Obstetrics, Rigshospitalet, from 1978 to 1985 and coupling between mother and child was possible through the Danish Civil Registrar System. We included singletons only, and if more than one sibling from the study-period met criteria for inclusion, only the oldest was invited. The protocol was in accordance with the Helsinki declaration and approved by the local ethical committee. All participants gave a written consent before taking part in the survey. Model. We sought a model to evaluate the possible impact of exposure to intrauterine hyperglycemia in both subjects with a relatively high genetic predisposition to type 2 diabetes and subjects with a relatively low genetic predisposition. (25) . Classification of diabetes-type was based on history, medical records, and levels of fasting C-peptide and GAD65ab. Pre-diabetes was defined as either impaired glucose tolerance or impaired fasting glucose. Exposure. We used "group" (O-GDM, O-NoGDM, O-Type1 and O-BP) as an estimate of different levels of intrauterine hyperglycemia in analyses including all offspring. In a sub-analysis of offspring born to women having an OGTT during pregnancy we included either fasting or 2-h blood glucose from this OGTT in the analyses. In women with type 1 diabetes estimates of mean blood glucose in the first trimester and in late pregnancy were available, and the predictive value of these variables were tested for O-Type1. Potential confounding covariates. Socioeconomic position was based on the highest occupational status of the parents at present, and coded into family social class I-V in accordance with the standards of the Danish National Institute of Social Research, similar to the British Registrar General's Classification I-V. We added a social class VI representing people on transfer income, including sickness benefits and disability pension (26) , and dichotomized the variable into, family social class (V-VI vs. I-IV). Ethnic origin was defined as Nordic Caucasian if the mother originated from Denmark, Norway, Sweden or Island, (yes vs. no). Paternal diabetes was defined as unspecified diabetes at follow-up, (yes vs. no). Maternal family history of diabetes was defined as unspecified diabetes in a first degree relative on maternal side, (yes vs. no). Maternal smoking during pregnancy was entered (≥1 cigarette per day, yes vs. no), age at delivery (<25 vs. ≥25 years), parity (≥1 partus vs. nulliparity), and pregestational BMI (≥25 vs. <25kg/m 2 ). Offspring sex was entered (male vs. female), physical activity (≥30 vs. <30 minutes per day), current smoking (≥1 cigarette per day, yes vs. no) and age (years).
We considered offspring BMI (≥25 vs. <25kg/m 2 ), to be a possible mediating covariate in the casual pathway from exposure to intrauterine hyperglycemia to glucose metabolism in the offspring.
The offspring were defined as smallor large for gestational age (SGA and LGA respectively) according to a Danish standard population (27) . In O-GDM and especially in O-Type1 birth weight, gestational age and offspring risk of becoming LGA were extensively influenced by factors attributed to the disease as well as to interventions related to the treatment. Therefore we considered the following covariates as both potential mediators and proxy variables for the two treated groups (O-GDM, O-Type1): Preterm delivery (<37 weeks gestation, yes vs. no), birth weight (gram), gestational age (days), SGA (yes vs. no) and LGA (yes vs. no).
To deal with this we studied the possible effect of these variables on offspring risk of type 2 diabetes/pre-diabetes without the "group"-covariate in the model. We did analyses including offspring from all four groups together but also analyses separately for offspring in the two treated groups (O-GDM and O-Type1) and offspring in the two untreated groups (O-NoGDM and O-BP). Statistical analyses. Continuous variables are given as mean (standard deviation) or geometric means (2.5-97.5 percentiles).
Differences between groups were analyzed with Chi 2 , ANOVA or Students T-test when appropriate. Non-normally distributed data were log-transformed before analysis. Post hoc tests were corrected for multiple comparisons using the Bonferroni method. P-values were multiplied by four as we compared O-BP with the other three groups as well as O-GDM with O-NoGDM. First we did simple logistic regression analyses giving the unadjusted OR of having type 2 diabetes/pre-diabetes for each of the covariates. Secondly we used a "change-in-estimate method" (28) to assess confounding. Covariates that altered the unadjusted odds ratios (OR) of type 2 diabetes/pre-diabetes more than 10% were considered confounders. Multiple logistic regression models included only confounders and they were not reduced. The results of the logistic regression analyses are expressed as OR and 95% confidence intervals (CI). All tests were two-tailed, and a significance level of 0.05 was chosen. Data were processed using SPSS (version 13.0;SPSS, Chicago, IL).
RESULTS
Characteristics
of the study population. The overall participation rate in the study was 56% (597/1066) (figure 1). Among the subjects lost to follow-up: 40% did not respond, 34% refused to participate, 10% had emigrated, 6% did not show up, 5% had died and 5% had other reasons for not to participate. The participation rate was comparable in the four groups. Also the prevalence of more than one risk indicator was comparable (21% vs.15%, P=0.2), but slightly more mothers of O-GDM had GDM previously (9 vs. 2%, P=0.02). As expected, women with GDM had a higher fasting (5.2 vs. 4.7 mmol/l) and 2-hour glucose (7.8 vs. 5.2 mmol/l), P<0.001.
Women with type 1 diabetes had 12 years (5-95 percentiles, 2-23) duration of diabetes and 52% had late diabetic complications (retinopathy or nephropathy). The majority was on 2 or 4 times insulin per day with insulin dosage increasing from 42 IU (23-66) to 73 IU (44-111) daily during pregnancy. Twice during pregnancy women with type 1 diabetes were hospitalized for 3 days and blood glucose was measured 7 times/day in capillary whole blood. In the first trimester the mean blood glucose was 8.9 mmol/l (2.8 mmol/l) and in late pregnancy, within the last 4 weeks before the estimated date of delivery, it was 6.8 mmol/l (1.8 mmol/l).
Data at follow-up. Maternal age at delivery, ethnicity, smoking during pregnancy, parity, paternal diabetes status at follow-up, family social class, sex, offspring physical activity and offspring smoking habits were not found to be confounders and had no effect on offspring risk of type 2 diabetes/pre-diabetes when entered in multiple logistic regression models. We found no interaction between "group" and the covariates in the two models.
No associations between birth weight, gestational age, preterm delivery, LGA and SGA and offspring risk of type 2 diabetes/pre-diabetes were found. Neither when all offspring were studied together nor when studied in subgroups. Furthermore ORs for type 2 diabetes/pre-diabetes did not change significantly when these variables were forced into the logistic regression models.
CONCLUSIONS
We found a high prevalence of type 2 diabetes/pre-diabetes among adults exposed to a hyperglycemic intrauterine environment. More than 20% of offspring born to mothers with diettreated GDM and more than 10% of offspring born to mothers with type 1 diabetes had type 2 diabetes/prediabetes at the age of 22 years. Compared to offspring from the background population the adjusted risk of type 2 diabetes/pre-diabetes were 8-and 4-fold increased, respectively, and this was not explained by differences in offspring overweight, birth weight or gestational age. Furthermore, we found an association between elevated maternal blood glucose in late pregnancy and type 2 diabetes/prediabetes in offspring of women with type 1 diabetes.
Strengths and limitations of this study. We have a high number of subjects with long-term follow-up, a high participation-rate, an internal controlgroup and data on many potential confounding covariates including paternal diabetes status, social class and physical activity as well as data on levels of C-peptide and GAD65ab in the offspring. A low prevalence of GDM in our background population has previously been documented (21) suggesting that the majority had a normoglycaemic intrauterine milieu both in the O-BP and the O-NoGDM. Undiagnosed cases of GDM among mothers to O-BP would only push our results towards the null-hypothesis and thus underrate the difference between the O-BP and the three other groups. Pregnant women with type 1 diabetes had documented high plasma glucose values during pregnancy and although we did not document high glucose levels continuously during pregnancy in the treated GDM mothers we have previously demonstrated an impact of a hyperglycemic milieu on the fetus in a similar group of diet treated women with GDM (29) suggesting a hyperglycemic environment also in O-GDM. However, we are aware that diet-treatment after the diagnosis of GDM may reduce the predictive value of glycemia during OGTT leading to an underestimation of the difference between O-GDM and ONoGDM. Nevertheless "Group" as well as fasting or 2-h glucose are crude estimates of maternal glucose metabolism during pregnancy. In the two groups with a relatively high genetic predisposition in our model, we have documented a higher prevalence of maternal family history of diabetes (30 and 35%) compared to the two groups with a low genetic predisposition (16 and 20%) . According to our model the observed differences in the prevalence of type 2 diabetes/pre-diabetes between O-GDM and O-NoGDM (21% vs. 12%) and between O-Type1 and O-BP (11% vs. 4%) may be interpreted as an effect of maternal hyperglycemia whereas the differences between O-GDM and OType1 (21% vs. 11%) and between ONoGDM and O-BP (12% vs. 4%) may be interpreted as an effect of genetics (online appendix 1). These indications of an effect of maternal hyperglycemia are supported by multiple logistic regression analysis, as OR for type 2 diabetes/pre-diabetes were higher in OType1 compared to O-BP (4.02, 1.31-12.33) as well as in O-GDM-compared to O-NoGDM (1.74, 0.89-3.40) , even though the later didn't reach the level of significance. Finally, the significant association between higher glucose levels in late pregnancy and type 2 diabetes/pre-diabetes in O-Type1 supports the hypothesis that intrauterine hyperglycemia plays a role for the pathogenesis of type 2 diabetes in the offspring. We find that bias from losses to follow-up is unlikely. Long-term studies of the risk of type 2 diabetes in normoglycemic women with risk indicators for GDM (the O-NoGDM group) are lacking, and whether the observed difference in the prevalence of type 2 diabetes/pre-diabetes between O-GDM and O-NoGDM is due to a more pronounced intrauterine hyperglycemia in O-GDM, "stronger" genetic predisposition, postnatal environmental factors or a combination cannot be further elucidated from our data.. A more ideal control-group of the O-GDM might have been discordant siblings, but that model weren't feasible in our population with the low GDM rate and the screening program used.
The high prevalence of type 2 diabetes/pre-diabetes in adult offspring of women with type 1 diabetes has not previously been documented but is in accordance with studies of children born to women with type 1 diabetes (14, 16) . Furthermore a small study found a higher prevalence of impaired glucose tolerance and decreased insulin secretion among adult offspring of mothers-compared to offspring of fathers with type 1 diabetes (17) .
The significant association between higher glucose levels in late pregnancy in mothers with type 1 diabetes and the incidence of type 2 diabetes/prediabetes in the offspring has not been reported previously, but is supported by the finding of an association between maternal 2-h glucose during OGTT and offspring glucose metabolism in glucose tolerant Pima Indians (30) .
This study is the first to show a high prevalence of type 2 diabetes/prediabetes in adult offspring of mothers with GDM in a primarily Caucasian population. This finding is in accordance with results from high-risk populations (11) as well as studies of children from Caucasian populations (14, 16) .
Abnormal glucose tolerance is associated with either decreased insulin secretion, decreased insulin sensitivity or a combination of both. The few human studies looking into this in offspring of diabetic women give various results with decreased insulin sensitivity reported by some authors (31) (14, 32, 33) and decreased insulin secretion by others (14, 17, 34 
FIGURE 1
Heading: Subjects in the study stratified according to relative genetic predisposition to type 2 diabetes and exposure to intrauterine hyperglycemia Subtext: O-GDM, offspring of women with diet-treated GDM; O-NoGDM, offspring of women who were screened for GDM because of risk indicators, but had a normal OGTT; OType 1, offspring of women with type 1 diabetes; O-BP, offspring of women from the background population; O-GDM : Offspring of women with diet-treated GDM
